Evidence map›Paper›PMID 39660611›Full record

ArticleeLife2024

Novel class IIb microcins show activity against Gram-negative ESKAPE and plant pathogens.

Benedikt M Mortzfeld, Shakti K Bhattarai, Vanni Bucci

Abstract read
In one paragraph

Article in eLife, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed.

  1. Article
  2. Review
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

3 authors.

Benedikt M MortzfeldProgram in Microbiome Dynamics, University of Massachusetts Chan Medical School, Worcester, United States.ORCID https://orcid.org/0000-0003-0563-8970
Shakti K BhattaraiProgram in Microbiome Dynamics, University of Massachusetts Chan Medical School, Worcester, United States.ORCID https://orcid.org/0000-0001-9118-9184
Vanni BucciProgram in Microbiome Dynamics, University of Massachusetts Chan Medical School, Worcester, United States.ORCID https://orcid.org/0000-0002-3257-2922

Funding

Aging Microbiome, Immunosenescence, and risk of Multi-drug Resistant Organism Colonization and Infection in the Nursing HomeR01AG075283 · NIA · UNIV OF MASSACHUSETTS MED SCH WORCESTER · PI Vanni Bucci, John Patrick Haran · 2023 to 2026
$2.8M
Congressionally Directed Medical Research Programs W81XWH2020013Deutsche Forschungsgemeinschaft 457837076NIA NIH HHS R01 AG075283NIH HHS 1R01AG075283-01A1
6 · The paper itself

Abstract

Interspecies interactions involving direct competition

Indexed as

Anti-Bacterial AgentsBacteriocinsEnterobacteriaceaeGram-Negative BacteriaMicrobial Sensitivity TestsPlant DiseasesAnti-Bacterial AgentsBacteriocinsmicrocinacinetobacter baumanniiantimicrobial peptidesclass IIb microcinsE. coliecologyESKAPEinfectious diseasemicrobiologymultidrug resistancesiderophore

Identifiers

PMID39660611
PMCPMC11634061

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.